OBJECTIVE: The objective of the study was to develop a clinical confocal microlaparoscope for imaging ovary epithelium in vivo with the long-term objective of diagnosing cancer in vivo. STUDY DESIGN: A confocal microlaparoscope was developed and used to image the ovaries of 21 patients in vivo using fluorescein sodium and acridine orange as the fluorescent contrast agents. RESULTS: The device was tested in vivo and demonstrated to be safe and function as designed. Real-time cellular visualization of ovary epithelium was demonstrated. CONCLUSION: The confocal microlaparoscope represents a new type of in vivo imaging device. With its ability to image cellular details in real time, it has the potential to aid in the early diagnosis of cancer. Initially the device may be used to locate unusual regions for guided biopsies. In the long term, the device may be able to supplant traditional biopsies and allow the surgeon to identify early-stage ovarian cancer. 2010 Mosby, Inc.
OBJECTIVE: The objective of the study was to develop a clinical confocal microlaparoscope for imaging ovary epithelium in vivo with the long-term objective of diagnosing cancer in vivo. STUDY DESIGN: A confocal microlaparoscope was developed and used to image the ovaries of 21 patients in vivo using fluorescein sodium and acridine orange as the fluorescent contrast agents. RESULTS: The device was tested in vivo and demonstrated to be safe and function as designed. Real-time cellular visualization of ovary epithelium was demonstrated. CONCLUSION: The confocal microlaparoscope represents a new type of in vivo imaging device. With its ability to image cellular details in real time, it has the potential to aid in the early diagnosis of cancer. Initially the device may be used to locate unusual regions for guided biopsies. In the long term, the device may be able to supplant traditional biopsies and allow the surgeon to identify early-stage ovarian cancer. 2010 Mosby, Inc.
Authors: Saurabh Srivastava; Jeffrey J Rodríguez; Andrew R Rouse; Molly A Brewer; Arthur F Gmitro Journal: J Biomed Opt Date: 2008 Mar-Apr Impact factor: 3.170
Authors: Ralf Kiesslich; Juergen Burg; Michael Vieth; Janina Gnaendiger; Meike Enders; Peter Delaney; Adrian Polglase; Wendy McLaren; Daniela Janell; Steven Thomas; Bernhard Nafe; Peter R Galle; Markus F Neurath Journal: Gastroenterology Date: 2004-09 Impact factor: 22.682
Authors: Anthony A Tanbakuchi; Andrew R Rouse; Joshua A Udovich; Kenneth D Hatch; Arthur F Gmitro Journal: J Biomed Opt Date: 2009 Jul-Aug Impact factor: 3.170
Authors: Jenna L Mueller; Jennifer E Gallagher; Rhea Chitalia; Marlee Krieger; Alaattin Erkanli; Rebecca M Willett; Joseph Geradts; Nimmi Ramanujam Journal: J Cancer Res Clin Oncol Date: 2016-04-22 Impact factor: 4.553
Authors: Jenna L Mueller; Henry L Fu; Jeffrey K Mito; Melodi J Whitley; Rhea Chitalia; Alaattin Erkanli; Leslie Dodd; Diana M Cardona; Joseph Geradts; Rebecca M Willett; David G Kirsch; Nimmi Ramanujam Journal: Int J Cancer Date: 2015-06-03 Impact factor: 7.396
Authors: Gabriel V Orsinger; Jennifer M Watson; Michael Gordon; Ariel C Nymeyer; Erich E de Leon; Johnathan W Brownlee; Kenneth D Hatch; Setsuko K Chambers; Jennifer K Barton; Raymond K Kostuk; Marek Romanowski Journal: J Biomed Opt Date: 2014-03 Impact factor: 3.170
Authors: Travis W Sawyer; Jennifer W Koevary; Caitlin C Howard; Olivia J Austin; Photini F S Rice; Gabrielle V Hutchens; Setsuko K Chambers; Denise C Connolly; Jennifer K Barton Journal: Lasers Surg Med Date: 2020-04-20 Impact factor: 4.025
Authors: Matthew D Risi; Andrew R Rouse; Setsuko K Chambers; Kenneth D Hatch; Wenxin Zheng; Arthur F Gmitro Journal: Int J Gynecol Cancer Date: 2016-02 Impact factor: 3.437